{"id":"delapril-delapril-manidipine-fixed-combination","safety":{"commonSideEffects":[{"rate":null,"effect":"Cough"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Hyperkalemia"},{"rate":null,"effect":"Peripheral edema"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Delapril inhibits angiotensin-converting enzyme (ACE), preventing the conversion of angiotensin I to angiotensin II, thereby reducing vasoconstriction and aldosterone secretion. Manidipine blocks L-type calcium channels in vascular smooth muscle, causing direct vasodilation. The fixed combination provides complementary antihypertensive effects through two distinct mechanisms.","oneSentence":"Delapril is an ACE inhibitor that reduces blood pressure by blocking angiotensin II formation, combined with manidipine, a calcium channel blocker that causes vasodilation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:08:58.123Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT00157586","phase":"PHASE3","title":"Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2002-02","conditions":"Type 2 Diabetes","enrollment":342}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Delapril, Delapril-Manidipine Fixed combination","genericName":"Delapril, Delapril-Manidipine Fixed combination","companyName":"Mario Negri Institute for Pharmacological Research","companyId":"mario-negri-institute-for-pharmacological-research","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Delapril is an ACE inhibitor that reduces blood pressure by blocking angiotensin II formation, combined with manidipine, a calcium channel blocker that causes vasodilation. Used for Hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}